Valerio Therapeutics (0NWK.LSE) Q3 2024 Earnings

30SepConfirmed
Q3 2022
Q2 2024
Q3 2024
Q3 2024
-0.12
0.22
0.55
0.88

Details

Expected EPS
N/A
Actual EPS
N/A
Surprise EPS
0
Surprise Percent
+NaN%

Description

Valerio Therapeutics (0NWK.LSE) will report earnings of for Q3 2024 on September 30, 2024.

0 Comments

Share your thoughts